SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-025206
Filing Date
2021-02-02
Accepted
2021-02-02 06:05:02
Documents
13
Period of Report
2021-02-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d101844d8k.htm   iXBRL 8-K 27509
2 EX-10.1 d101844dex101.htm EX-10.1 338102
  Complete submission text file 0001193125-21-025206.txt   567640

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA aveo-20210201.xsd EX-101.SCH 3081
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE aveo-20210201_lab.xml EX-101.LAB 17373
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aveo-20210201_pre.xml EX-101.PRE 10960
6 EXTRACTED XBRL INSTANCE DOCUMENT d101844d8k_htm.xml XML 3271
Mailing Address 30 WINTER STREET BOSTON MA 02108
Business Address 30 WINTER STREET BOSTON MA 02108 857-400-0101
AVEO PHARMACEUTICALS, INC. (Filer) CIK: 0001325879 (see all company filings)

IRS No.: 043581650 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34655 | Film No.: 21578900
SIC: 2834 Pharmaceutical Preparations